‘Xalost’ ophthalmic agent goes to 17 European countries

Published: 2012-02-08 06:56:00
Updated: 2012-02-08 06:56:00
Xalost (latanoprost) eye drop, a glaucoma drug, will be exported to 17 European countries, Taejoon Pharma announced on Monday.

Taejoon has recently received the marketing authorization for Xalost in Switzerland and Bulgaria following the approval from the German health ministry on April 2009.
...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.